Market
  • Company Info.

    Bandaram Pharma Packtech Ltd.

    Directors Report



    Market Cap.(`) 41.52 Cr. P/BV 3.44 Book Value (`) 10.07
    52 Week High/Low ( ` ) 48/24 FV/ML 10/1 P/E(X) 293.22
    Book Closure 30/09/2023 EPS (`) 0.12 Div Yield (%) 0.29
    You can view full text of the latest Director's Report for the company.
    Year End :2014-03
    The Members of Shiva Medicare Limited,

    The Directors have great pleasure in presenting their Annual Report along with the Audited Accounts for the year ended 31st March, 2014 together with the Auditor's Report thereon.

    OPERATIONS

    During the period under review, the Company has not done any business activity; hence there are no working Results.

    You must be pleased to know that the management of company has taken some concrete steps in order to revive the company and bring back the glories years of the company and thereby increasing share holders value. Some of the steps are as follows

    1) Resumption in Trading of Equity Shares of Company at BSE Ltd

    2) New Project Planning & Execution.

    3) Restructuring of Company's balance sheet through Capital Reduction.

    In fact we are pleased to inform you that the company has already received NoC for the draft Scheme of Capital Reduction from BSE Ltd and a special resolution with regards to the same has been proposed in this AGM.

    Once the company's capital is restructured and carry forward losses are set off, it would enable the management to explore various opportunities to enhance the net worth of the company through suitable means.

    With the above measure that the company has planned to initiate in the coming two years, the management of company is quite confident of increasing substantial share holder's value.

    DIVIDEND

    You directors have not recommended payment of any dividend during the period under review. DEPOSITS

    The Company has not accepted any deposits from the public during the year as such no amount of interest and principal was outstanding as of the date of the balance sheet.

    ENERGY CONSERVATION, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNING & OUTGO

    There was no business activity and hence no steps were taken for Conservation of Energy. There was no Technology Absorption, Foreign Exchange Earning and Outgo. There was no Technical Know How pursuant to sections 217(l)(e) of the Companies Act, 1956 read with the Companies (Disclosures of Particulars in the report of the Board of Directors) Rules 1988.

    PERSONNEL

    There was no employee who was in receipt of the remuneration for the year or part thereof as prescribed under Section 217(2A) of the Companies Act, 1956 relating to the Companies (Particulars of employees) Rules, 1975, is required to be annexed.

    DIRECTORS

    Sh. Amit Jain is retiring by rotation and is eligible for re-appointment in the ensuing Annual General Meeting.

    AUDITORS

    M/s. Rama Chandra Rao. Chartered Accountant, Hyderabad Auditors of the Company retires at the ensuing Annual General Meeting and being eligible offer themselves for re-appointment.

    DIRECTORS' RESPONSIBILITY STATEMENT

    Pursuant to the requirement under Section 217(2AA) of the Companies Act, 1956 with respect to Director's Responsibility Statement, it is hereby confirmed:

    a) That in preparation of the Annual Accounts for the financial year ended 31st March, 2014; the applicable accounting standards have been followed along with proper explanation relating to material departures, if any. ;

    b) that the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that were reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit or loss of the Company for the year under review;

    c) that the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

    d) That the Directors had prepared the accounts for the financial year ended 31st March 2014 on a 'going concern' basis.

    ACKNOWLEDGEMENT

    The Directors wish to place on record their appreciation for the assistance, support and Co-operation to the Company.

                                        For and on behalf of the Board 
                                            For Shiva Medicare Limited
    

                                       Sd.                        Sd.
    

    Place: Hyderabad               AMIT JAIN               JOHN WILSON
    

    Date : 07.06.2014               DIRECTOR                  DIRECTOR
    

  • Bandaram Pharma Packtech Ltd.

    Company News



    Market Cap.(`) 41.52 Cr. P/BV 3.44 Book Value (`) 10.07
    52 Week High/Low ( ` ) 48/24 FV/ML 10/1 P/E(X) 293.22
    Book Closure 30/09/2023 EPS (`) 0.12 Div Yield (%) 0.29
    You can view the latest news of the Company.

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html